Transportation and Transit Services
Closed Special Notice Posted
- Solicitation number
- 75F40124R00049
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- Competitive 8(a)
Opportunity facts
- NAICS code
- 485410 School and Employee Bus Transportation
- Place of performance
- Silver Spring, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Food and Drug Administration (FDA) has issued a Special Notice for transportation, transit, and parking related services on the White Oak Campus located in Silver Spring, Maryland. The FDA intends to award a single contract through a fair opportunity competition after excluding sources, under the 8(a) program.
The purpose of this Special Notice is to provide an opportunity for interested 8(a) contractors to identify their interest and capabilities in responding to this requirement. The due date for submitting responses is May 16, 2024 by 12:00 PM EST. The FDA will use the responses received to determine if a set-aside 8(a) competition is necessary or if full and open competition is required. Eligible contractors must be 8(a) certified, and the government retains sole discretion in deciding whether to proceed with the 8(a) set-aside or open competition approach.
Notice text
2 versions
Update #2 · Latest ·
Notice of Fair Opportunity - 8(a) After Exclusion of Sources
The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award from a fair opportunity competition After Exlusion of Sources, based on a result of an RFI 75F40124R00005, issued on 10/06/23 - to provide transportation, transit, and parking related services for the Food and Drug Administration (FDA) Services on the White Oak Campus (WO), located at 10903 New Hampshire Ave, Silver Spring, Maryland 20993.
The propose this acquisition After Exclusion of Sources, is for the Government to solicit and negotiate with identified source only. Interested parties may identify their interests and capabilities, to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed acquisition, as 8(a) Set Aside - After Exclusion of Sources, based upon responses to this notice, is solely within the discretion of the Government.
Information received will normally be considered solely for the purpose of determining, not to conduct a set aside competitive requirement. No further solicitation is available.
FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by May 16, 2024, 12:00 PM EST.
Update #1 ·
Notice of Fair Opportunity - 8(a) After Exclusion of Sources
The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award from a fair opportunity competition After Exlusion of Sources, based on a result of an RFI 75F40124R00005, issued on 10/06/23 - to provide transportation, transit, and parking related services for the Food and Drug Administration (FDA) Services on the White Oak Campus (WO), located at 10903 New Hampshire Ave, Silver Spring, Maryland 20993.
The propose this acquisition under the exclusion of sourcesl, is for the Government to solicit and negotiate with identified source only. Interested parties may identify their interests and capabilities to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed acquisition, as 8(a) Set Aside - After Exlusion of Sources, based upon responses to this notice, is solely within the discretion of the Government.
Information received will normally be considered solely for the purpose of determining, not to conduct a set aside competitive requirement. No further solicitation is available.
FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by May 16, 2024, 12:00 PM EST.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity